Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 4:51 AM UTC
| NCT Number | NCT06167317 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 278 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | August 13, 2026 (2 weeks ago) |
As of August 31, 2026: Clinical trial NCT06167317 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 5 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06167317 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06167317 was last updated 2 weeks ago (August 13, 2026). HelloStudys verifies this status automatically.